Regenxbio Inc
Change company Symbol lookup
Select an option...
RGNX Regenxbio Inc
OGSYS Otis Gallery LLC
RDN Radian Group Inc
SLNO Soleno Therapeutics Inc
REI Ring Energy Inc
FSHOX Fidelity® Select Construction & Housing Portfolio
NNN NNN REIT Inc
UTHR United Therapeutics Corp
KEX Kirby Corp
DDOG Datadog Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

REGENXBIO Inc. is a clinical-stage biotechnology company, which is focused on providing curative potential of gene therapy. Its investigational gene therapies are designed to deliver functional genes to address genetic defects in cells. The Company’s investigational AAV Therapeutics include RGX-314, RGX-202, RGX-121, RGX-111 and RGX-181 and RGX-381. RGX-314 is meant for the treatment of large patient populations impacted by wet age-related macular degeneration (wet AMD), diabetic retinopathy and other chronic retinal diseases. RGX-202 is developed to treat Duchenne muscular dystrophy, one of the common fatal genetic disorders affecting children. RGX-121, RGX-111 and RGX-181 are developed to treat Mucopolysaccharidosis type II, Mucopolysaccharidosis type I, and late infantile neuronal ceroid lipofuscinosis type II (CLN2 disease), all of which are progressive, neurodegenerative lysosomal storage disorders. RGX-381 is developed to treat the ocular manifestations of CLN2 disease.

Closing Price
$18.56
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
434,410

10-day average volume:
466,934
434,410

Thinking about buying stock in Elevation Oncology, Credit Suisse, PacWest Bancorp, Atlas Air, or Marathon Digital?

10:51 am ET March 15, 2023 (PR Newswire) Print

InvestorsObserverissues critical PriceWatch Alerts for ELEV, CS, PACW, AAWW, and MARA.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- ELEV: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=ELEV&prnumber=031520235

-- CS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CS&prnumber=031520235

-- PACW: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=PACW&prnumber=031520235

-- AAWW: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=AAWW&prnumber=031520235

-- MARA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=MARA&prnumber=031520235

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG43338&sd=2023-03-15

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-elevation-oncology-credit-suisse-pacwest-bancorp-atlas-air-or-marathon-digital-301773059.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG43338&Transmission_Id=202303151051PR_NEWS_USPR_____CG43338&DateId=20230315

comtex tracking

COMTEX_426679158/1005/2023-03-15T10:51:08

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.